Mon.Oct 12, 2020

Get ready for HUGE healthcare changes

World of DTC Marketing

There is going to be more coverage for virtual doctors’ visits in new employee health plans along with expanded mental health benefits and access to on-site health clinics. Of course, this comes at an increased cost even though health insurers are making a lot of money.

Mallinckrodt, beset by opioid drug suits, files for bankruptcy

Bio Pharma Dive

The drugmaker aims to resolve billions of dollars in opioid-related claims and a federal lawsuit over Medicaid rebates, liabilities it says would be "otherwise unmanageable "

Drugs 147

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

A Dose of Optimism, as the Pandemic Rages On

NY Times

The months ahead will be difficult. But the medical cavalry is coming, and the rest of us know what we need to do


Alkermes' comeback bid boosted by FDA panel backing for schizophrenia drug

Bio Pharma Dive

While the committee's votes in favor of ALKS 3831 make an approval more likely, the drug's effects on patients also taking opioids could limit its use

Drugs 142

The ur-Iris likely had purple flowers, pollinated by insects for nectar


The Race for a Super-Antibody Against the Coronavirus

NY Times

A network of scientists is chasing the pandemic’s holy grail: an antibody that protects against not just the virus, but also related pathogens that may threaten humans

More Trending

AZ’s long-acting COVID-19 antibody moves into phase III

Pharma Times

Two trials will involve over 6,000 participants at sites in and outside the US

First, a Vaccine Approval. Then ‘Chaos and Confusion.’

NY Times

Come spring, Americans may have their choice of several so-so coronavirus vaccines — with no way of knowing which one is best

When reproductive rights are less restrictive, babies are born healthier


Dupixent Posts Positive Results in Phase III Pediatric Asthma Study


In a Phase III study, the biologic met primary and all key secondary endpoints in children ages 6 to 11 who have uncontrolled moderate-to-severe asthma


HIV epidemic: Successful use of self-tests in rural Africa


Credit: University of Basel / Swiss TPH, Alain Amstutz Despite significant progress in prevention and therapy, millions of people still get infected with HIV every year. The main burden of HIV/AIDS falls on Africa.

UK joins global trial to test BCG vaccine against COVID-19

BioPharma Reporter

A global trial, designed to test the theory that the BCG vaccine could help protect against COVID-19, will soon start recruitment in the UK. Bio Developments

Oncotarget: miR-708-5p targets oncogenic prostaglandin E2 production in lung cancer cell


Volume 11, Issue 26 of Oncotarget reported that Lung cancer is of particular importance, as it is the deadliest cancer worldwide. Credit: Correspondence to – Carol S.

Professor Charged in Chinese Funds Coverup Case Wants Harvard to Foot His Legal Bill


Charles M. Lieber is currently on paid leave from Harvard’s chemistry department after his arrest in January on charges of lying to the U.S. government about funds received from China


Brain regions with impaired blood flow have higher tau levels


As Alzheimer’s disease progresses, more brain regions exhibit the relationship Credit: Albrecht et al., JNeurosci 2020 In Alzheimer’s disease, impaired blood flow to brain regions coincides with tau protein buildup.

Biopharma Update on the Novel Coronavirus: October 13


Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 13, 2020


UMD astronomers find x-rays lingering years after landmark neutron star collision


New, most complete start-to-finish view of neutron star merger rewrites the way scientists understand these events Credit: Image credit: E. Troja It’s been three years since the landmark detection of a neutron star merger from gravitational waves.

How Much Biz Dev Should Sites and Job Seekers Be Doing?

Clinical Trial Gurus

Business development is an important part of building a clinical research site yet sites don’t do enough business development. All sites are therefore encouraged to dedicate a significant amount of time to obtaining study leads as well as following up with them.

Ancient tiny teeth reveal first mammals lived more like reptiles


Credit: Graphics: Nuria Melisa Morales Garcia.

J&J Taps the Brakes on COVID-19 Vaccine Trial After “Unexplained Illness"


J&J did not disclose much information about the unexplained illness, stating, “We must respect this participant’s privacy. We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information

Crayfish ‘trapping’ fails to control invasive species


Credit: Eleri Pritchard Despite being championed by a host of celebrity chefs, crayfish ‘trapping’ is not helping to control invasive American signal crayfish, according to new research by UCL and King’s College London.

Open communication helps ulcerative colitis patients through COVID-19

Pharma Phorum

Gastroenterologist Dr Séverine Vermeire explains how lockdowns and communication changes over COVID-19 are taking their toll on ulcerative colitis patients and how we can best support them in the new normal.

Clinical study aims to better understand COVID-19 immunity


Credit: Walter and Eliza Hall Institute of Medical Research. People who have recovered from COVID-19, and their close contacts, could hold the key to understanding how immunity to the disease develops, how long it lasts and what happens when immunity is lost.

UK biotech sector sets new record with more than £1bn investment in Q3

Pharma Phorum

There has been a well-publicised boom in biotech investment during the pandemic, and the UK is no exception, with a record £1 billion raised in the third quarter.

Tighter border policies leave migrants vulnerable to effects of climate change


Open borders strengthen developing countries economically Credit: Egan Jimenez, Princeton University PRINCETON, N.J.–As

BMS’ Zeposia hits the mark in ulcerative colitis

Pharma Times

Oral S1P receptor modulator hit both primary endpoints in a phase III trial

Eyeglass-attached display device provides fluoroscopic guidance during spine surgery


Credit: Copyright 2020 AANS. CHARLOTTESVILLE, VA (OCTOBER 13, 2020). The authors, two surgeon-researchers from Murayama Medical Center in Tokyo, tested a device that, when attached to everyday eyeglasses, can display fluoroscopic images used for surgical guidance directly to the surgeon.

Gossamer Bio’s GB001 Shows Minimal Impact in Asthma and Chronic Rhinosinusitis


Gossamer Bio announced today that its two studies examining GB001 – the Phase IIb LEDA trial in eosinophilic asthma and Phase II TITAN trial in chronic rhinosinusitis – failed to meet their primary endpoints

Therapy using immune system cells preserves vision in mice implanted with rare eye cancer


Credit: UNC Lineberger CHAPEL HILL, N.C.–A –A treatment that uses immune system T cells, combined with an immune-boosting drug packaged in an injectable gel, was found to preserve the vision of mice implanted with tissue from a human eye cancer known as retinoblastoma.

Exploding Biopharma Industry Going the Distance for Specialized Talent


The urgency of 2020 has shone a spotlight on the investment and advances in the U.S. biotech industry over the past decade – and overall, it is looking strong


Chemists create new crystal form of insecticide, boosting its ability to fight mosquitoes and malaria


CPhI: Dramatic changes ahead for the generics market

Outsourcing Pharma

Technology impacting generic drugs include artificial intelligence, telemedicine, fraud-preventing digital solutions and more, according to a report. Markets & Regulations

Primates aren’t quite frogs


Spinal modules in macaques can independently control forelimb force direction and magnitude Credit: The National Center of Neurology and Psychiatry Japan — Researchers in Japan demonstrated for the first time the ‘spinal motor module hypothesis’ in the primate arm, opening a new pathway for recovery after disease or injury.

NANOBIOTIX Announces First Patient Injected with NBTXR3 in Pancreatic Cancer and Safe to Proceed Notifications for Two Additional Trials From U.S. FDA

BioTech 365

First patient injected in phase I trial evaluating NBTXR3 activated by radiation therapy for patients with pancreatic cancer at The University of Texas MD Anderson Cancer Center in clinical collaboration with Nanobiotix ‘Safe to proceed’ notifications have been received from … Continue reading → Business Wire